CollPlant Biotechnologies Ltd - ADR

NASDAQ:CLGN   3:59:43 PM EDT
13.65
-0.25 (-1.80%)
Products

Collplant And United Therapeutics Announce Collaboration To Include 3D Bioprinting Of Human Kidneys For Transplant

Published: 09/21/2020 11:25 GMT
CollPlant Biotechnologies Ltd - ADR (CLGN) - Collplant and United Therapeutics Announce Exercise of Option That Will Expand Their Collaboration to Include 3d Bioprinting of Human Kidneys for Transplant.
United Therapeutics Corp - Paid Collplant $3 Million for Option Exercise.
United Therapeutics Corp - Collplant Received an Upfront Payment of $5 Million and Will Receive Milestone Payments of Up to $15 Million.
United Therapeutics - Collplant Will Also Be Entitled to Royalties on Sales of Commercialized Products Covered by Patents Licensed From Collplant.